141109-21-9

Basic information

• Product Name: BENZENEACETIC ACID, 2-CHLORO-A-[[2-(2-THIENYL)ETHYL]AMINO]-, METHYL ESTER, (+)-, (1S)-7,7-DIMETHYL-2-OXOBICYCLO[2.2.1]HEPTANE-1-METHANESULFONATE
• Synonyms: BENZENEACETIC ACID, 2-CHLORO-A-[[2-(2-THIENYL)ETHYL]AMINO]-, METHYL ESTER, (+)-, (1S)-7,7-DIMETHYL-2-OXOBICYCLO[2.2.1]HEPTANE-1-METHANESULFONATE
• CAS NO: 141109-21-9
• Molecular Formula: C15H16ClNO2S.C10H16O4S
• Molecular Weight: 542.114
• Mol File: 141109-21-9.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: BENZENEACETIC ACID, 2-CHLORO-A-[[2-(2-THIENYL)ETHYL]AMINO]-, METHYL ESTER, (+)-, (1S)-7,7-DIMETHYL-2-OXOBICYCLO[2.2.1]HEPTANE-1-METHANESULFONATE(CAS DataBase Reference)
• NIST Chemistry Reference: BENZENEACETIC ACID, 2-CHLORO-A-[[2-(2-THIENYL)ETHYL]AMINO]-, METHYL ESTER, (+)-, (1S)-7,7-DIMETHYL-2-OXOBICYCLO[2.2.1]HEPTANE-1-METHANESULFONATE(141109-21-9)
• EPA Substance Registry System: BENZENEACETIC ACID, 2-CHLORO-A-[[2-(2-THIENYL)ETHYL]AMINO]-, METHYL ESTER, (+)-, (1S)-7,7-DIMETHYL-2-OXOBICYCLO[2.2.1]HEPTANE-1-METHANESULFONATE(141109-21-9)

Safety Data

• Hazardous Substances Data: 141109-21-9(Hazardous Substances Data)

Upstream product

• 141109-18-4 methyl [2-(thien-2-yl)ethylamino](2-chlorophenyl)-acetate hydrochloride 
• 3144-16-9 (1S)-10-camphorsulfonic acid 
• 141109-26-4 2-(2-thiophen-2-yl ethylamino)(2-chlorophenyl)acetic acid methyl ester 
• 61380-66-3 L-10-camphorsulfonic acid 

Relevant articles and documents

Clopidogre and wherein the intermediate α-bromo-ortho-chlorophenyl acetic acid and α-thiophene substituted ethylamino- method for the preparation of acetic acid hydrochloride (by machine translation)

The invention discloses a preparation method of clopidogrel and intermediates thereof. The preparation method of the clopidogrel and intermediates thereof, provided by the invention, has the characteristics of being simple to operate, mild in reaction condition, little in pollution, low in energy consumption and the like and is suitable for industrial production, a high-purity intermediate can be provided for production of the clopidogrel, and the production cost of the clopidogrel is reduced.